🇺🇸 FDA
Pipeline program

HEC68498

HEC68498-P-01

Phase 1 small_molecule completed

Quick answer

HEC68498 for Advanced Refractory Solid Tumors is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Advanced Refractory Solid Tumors
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials